Knowledge of and access to screening in women with carcinoma of the cervix ín Brazil
DOI:
https://doi.org/10.32635/2176-9745.RBC.1992v38n2/3.3080Keywords:
Cervical Cancer, ScreeningAbstract
In order to assess the level of knowledge of screening for carcinoma of the cervix among women presenting with this condition, a survey of a consecutive series of patients was undertaken. AH 266 patients presenting at this hospital during 1988 for the treatment of carcinoma of the cervix completed a structured questionnaire about cervical câncer screening. A percentage of 68.8% patients had never been screened. Those patients who had not previously had a cervical smear test were more likely to be in the older age groups (over 45 years) and to come from low income groups with poor educatlon and poor access to medicai facilities. Even among patients who had previousiy had contacts with the medicai profession, only a minority (approximately 40%) had undergone cervical screening at any time. Since carcinoma of the cervix is currently the commonest malignant neoplasm in women in Brazil, it is evident that an urgent campaign is necessary to educate both the public and the medical profession in cervical screening, hopefully to reduce the very high rate of Invasive carcinoma of the cervix in this country.
Downloads
References
PAPANICOLAOU GN, TROUT HE. Diagnosis of Uterine Cancer by Vaginal Smears. The Commonwealth Fund, New York, 1943. DOI: https://doi.org/10.1097/00000441-194312000-00020
GUZICK DS. Efficacy of screening for cervical câncer. Am J Public Health, 1978;68:125-134. DOI: https://doi.org/10.2105/AJPH.68.2.125
MURPHIWM, COLEMAN SA. The long lerm course of carcinoma in situ of the uterine cervix. Cancer, 1976; 38; 957-963. DOI: https://doi.org/10.1002/1097-0142(197608)38:2<957::AID-CNCR2820380247>3.0.CO;2-Q
PARKIN DM, NGUYEN-DINH X, DAY NE. The impact of screening on the incidence of cenvix cancer in England and Wales. Br J Obstet Gynaecol 1985; 92:150-157. DOI: https://doi.org/10.1111/j.1471-0528.1985.tb01067.x
DAY NE. Effect of cenvical cancer screening in Scandinavia. Obstet Gynaecol 1984; 714-718.
SOOST HJ, BOCKMUHL HZ. Results of cytologic screening in the Federal Republic of Germany. Acta Cytologica, 1981; 26:445-452.
BOYES AD. The British Columbia screening program. Obstet Gynaecol Surv 1969; 1005-1011. DOI: https://doi.org/10.1097/00006254-196907001-00030
CHRISOPHERSON WM, PARKER JE, MENDES WM, LUNDIN FE Jr. Cervix cancer death rates and mass cytologic screening. Cancer, 1970; 26: 808-811. DOI: https://doi.org/10.1002/1097-0142(197010)26:4<808::AID-CNCR2820260411>3.0.CO;2-S
DICKINSON L, MUSSEY ME, KURLAND LT. Evaluation of the effectiveness of cytologic screening for cervical câncer: 11 survival parameters before and after inception of screening. Mayo Clin Proc 1972; 47: 545-549.
MacGREGOR JE, FRASER MER, MANN EMF. Improved prognosis for cervical cancer due to comprehensive screening. Acta Cytol 1972; 16:14-15.
BRUNINI R, TORLONI H, HENSON DE, GOTLIEB SLD, SOUZA JMP. Distribuição percentual das dez primeiras localizações de câncer primário segundo grandes regiões (Brasil 1976-80). In Câncer no Brasil dados histopatológicos - Ministério da Saúde, 1982: 4-8.
CUNHA MMP. Avaliação da rede laboratorial das secretarias estaduais da saúde. Rev Bras Cancerol 1985; 31: 213-220.
PARKIN DM, STYERNSWARD J, MUIR CS. Estimates of the worldwide frequency of twelve major cancers. Bulletin of the World Health Organization 1984; 62:163-182.
A WHO Meeting: Control of câncer the cervix uteri. Bulletin of the World Health Organization, 1986; 64: 607-618.
CAMPOS GP, BARBOSA RB, BANUELLOS A. Seminário de integração do setor para controle do câncer cérvico uterino. Divisão Nacional de Doenças Crônico-Degenerativas. Campanha Nacional de Combate ao Câncer, 1986: 2.
MILLER AB, LINDSAY J, HILL GB. Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. IntJ Câncer, 1976; 17:602-612. DOI: https://doi.org/10.1002/ijc.2910170508
MacGREGOR JE. On taking uterine cervical smears. Aberdeen. British Society for Clinicai Cytology, 1981.
DRAPER GJ. Screening for cervical câncer: revised policy. The recommendations of the DHSS committee on gynaecological cytology. Health Trends, 1982; 14:37-40.
ROBERTS A. Cervical cytology in England and Wales 1965-80, Health Trends, 1982; 41-43.
RYLANDER E. Cervical câncer in women belonging to a cytologically screened population. Acta Obstet Gynecol Scand, 1976; 55: 361-366. DOI: https://doi.org/10.3109/00016347609158514
FRUCHTER RG, BOYCE J, HUNT M. Missed opportunities for early diagnosis of cancer of the cervix. Am J Public Health, 1980; 70: 418-420. DOI: https://doi.org/10.2105/AJPH.70.4.418
GREENWALD P, NASCA PC, GORDON ED. Prevention of cérvix deaths through hospital screening. Ny State J Med 1972; 72: 742-745.
SARGEANT EJ, GIZILBASH AH, JOHNSON FL, Cervical cytology screening experience in a general hospital. Can Med Assoe J, 1977; 117:1026-1027.
HUDSON E, HEWERTSON S, JANSZ C, GORDON H. Screening hospital patients for uterine and cervical cancer. J Clin Pathol 1983; 36:611-615. DOI: https://doi.org/10.1136/jcp.36.6.611
